Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Nonetheless, the magnitude of weight reduction observed at higher doses is notable given that achieving substantial weight loss in individuals with type 2 diabetes has historically been more difficult than in those with obesity alone, partly due to the metabolic effects of the condition itself and certain antidiabetic medications
For example, the GSH intravenous administration in patients with Parkinsons disease determined significant improvements, which lasted for 24 months after the administration (26)
Fatty and sugary foods may lose their appeal , as the brain reprograms its response to highly caloric foods
Consult a healthcare professional experienced in GLP-1 medications before starting the medication to discuss your goals, pros and cons, risks, and cost and insurance considerations
If approved for weight management, general eligibility criteria would typically include: Body Mass Index (BMI) 30 kg/m (obesity), or BMI 27 kg/m (overweight) with at least one weight-related comorbidity such as type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea, or cardiovascular disease Age 18 years or older Previous unsuccessful attempts at weight loss through diet and exercise alone Commitment to a comprehensive weight management programme including dietary modification and increased physical activity NICE guidance may specify lower BMI thresholds for certain ethnic groups (particularly those of South Asian origin) who are at increased risk of complications at lower BMI levels
